Table of Contents

Do you want to write an article as a guest? Anonymous or pseudonymous contributions are OK (I worked in pharma too)! Send me an email and let me know what you want to write about.

Use [Ctrl]+F to "find" articles with a specific keyword.
  • “What Doctors Don’t Want”
  • $253M Lesson in Being Understood
  • A Brief Manifesto Designed For Newer Pharmaceutical Representatives
  • A CafePharma Poster Responds
  • A Look Before 2008 Ends…
  • Are Drug Reps Really Necessary?
  • Arm movement
  • Assumptions and false comparisons
  • AstraZeneca Proves that Ethics Cannot be Legislated
  • Attack of the Pharma Babes
  • Banned (Almost) from CafePharma!
  • Becoming an educational resource
  • Beyond Multiple Choice: 5 Best practices for clinical training
  • Big Pharma by John Prieve
  • Big Pharma Sexy Little Secret
  • Blogs Becoming a Changing Force For Industry
  • Blogs: The Prevention of Ignorance
  • Breaking into Pharmaceutical Sales
  • Can we bridge the clinical-sales divide: Collaboration Conundrum
  • Can we bridge the clinical-sales divide: Joint Calls
  • Clinical training: Creating the sales force of the future
  • Clinical trial endpoints
  • Clinical trials take drugs from the lab to the bedside
  • Communicating clinical information: Avoid the Kiss of Death
  • Competencies for the Quintessential Pharmaceutical Sales Professional
  • Confessions of a Pill Pusher
  • Contribute to compliance: The rep’s role in patient adherence
  • Crime and Punishment: Enough for Corporate Wrongdoing?
  • Do the Right Thing
  • Don’t go DEAF on a call
  • Easier Said Than Done: “Don’t Take It Personally”
  • Educating physicians and patients
  • EU Pharm Reps Downsizing
  • Fax – The Next Relationship Builder?
  • Find Out What Matters to Doctors in Clinical Context
  • Give doctors what they want
  • Good clinical practice: The foundation of clinical trial success
  • Greed and Hypocrisy are Generation-Blind
  • Guest Column: Pharma Sales v. Device Sales
  • Handling clinical study objections
  • How Industry Changes and Why Reps Should Care
  • Individual Accountability and How Doctors Are Also Businessmen
  • Industry Funding of CME: The Next Chapter
  • Innovation is Not Just for Drugs
  • It’s NOT “…the Patients, Stupid.”
  • Jane’s Clinical Training Article to Appear in Pharmaceutical Executive Supplement
  • Massachusetts May Start Requiring Licensing of Drug Reps
  • Meeting with (the Ex-) Viagra Salesman
  • Mother of Invention and “Disease Mongering”
  • No more spin! Putting clinical science back into clinical selling
  • Patient Adherence: More Than Economics
  • Pharma faces criticism of clinical trial practices
  • Pharma Nice Place to Work If Not Field-Based
  • Pharmaceutical Sales Representative Explains why Networking is a Day-to-Day Job
  • Pharmaceutical Science and Sales Are Not Mutually Exclusive, But Priorities Have Changed
  • Pharmacogenomics paves the way to personalized medicine
  • Phase I Trials and the TGN1412 Controversy
  • Poms Poms and Lunches
  • Resident Physicians Not Enamored with Drug Reps
  • Retrospective Analysis of Whistleblower Complaints Show that Sales Reps DO CARE About Ethics!
  • Routes of administration influence prescribing
  • Sales Reps as Spokesperson?
  • Sexy eDetailing
  • Short Clinical Calls: Most Important Part of a Clinical Study
  • Stanford Policy Aims to Minimize Influence of Pharma Gifts to Physician Decision Making
  • The Double-Edged Sword of Off-Label Prescribing
  • The value of p values
  • Think critically: How to read a clinical paper
  • Trusted Colleague or Sample Dropper?
  • Turn up the science
  • Two Recession-Proof Healthcare Careers, Part 1
  • Two Recession-Proof Healthcare Careers, Part 2
  • Watching the subject
  • What Reps Can Learn from CME Professionals
  • Who are the Rogues?
  • Who’s responsible? Bureaucracy botches adverse event reporting
  • Why Dr. Evans Established Rules for Reps
  • Will Pharm Reps Ever Be Replaced?